Prof. Dr. Karl Broich, President, Federal Institute for Drugs and Medical Devices (BfArM)

As a regulatory body the BfArM strongly supports AESGP’s vision of empowering people to take better care of their health. Especially digital technology with its increasing influence creates new opportunities here – as shown, for example, by digital health applications (called DiGA in Germany) that enable patients in many ways and can therefore be reimbursed in Germany. We appreciate the close and constructive cooperation with AESGP on European level and look forward to the milestones we will achieve together in the coming decades for even better healthcare for citizens in Europe.